Diseases, Conditions, Syndromes

Japan approves Moderna, AstraZeneca vaccines

Japan formally approved Moderna and AstraZeneca's COVID-19 vaccines on Friday, but the latter will not be used immediately because of lingering concern over very rare blood clots.

Vaccination

France recommends AstraZeneca jab for over-55s only

France's health regulator recommended Friday that only people aged 55 and over be administered AstraZeneca's COVID-19 vaccine due to reports of blood clots, while giving the green light to resume its use after a brief suspension.

Vaccination

US vaccinations ramp up as 2nd COVID-19 shot nears

Hundreds more hospitals around the country began dispensing COVID-19 shots to their workers in a rapid expansion of the U.S. vaccination drive Tuesday, while a second vaccine moved to the cusp of government authorization.

Vaccination

December vaccine rollout possible, BioNTech CEO says

BioNTech co-founder Ugur Sahin said on Thursday the frontrunner COVID-19 vaccine his German firm is developing with Pfizer could be rolled out before the year is over in the United States or Europe.

Vaccination

BioNTech's founders: scientist couple in global spotlight

Progress on a COVID-19 vaccine has propelled the modest husband-and-wife team behind German firm BioNTech into the global limelight, with attention inevitably focussing on their background as the children of Turkish immigrants.

page 36 from 40